AC
Amia Capital Portfolio holdings
AUM
$32.1M
1-Year Return
3.89%
This Quarter Return
-4.57%
1 Year Return
-3.89%
3 Year Return
+25.64%
5 Year Return
–
10 Year Return
–
AUM
$86.1M
AUM Growth
-$35.2M
(-29%)
Cap. Flow
-$29.9M
Cap. Flow
% of AUM
-34.8%
Top 10 Holdings %
Top 10 Hldgs %
85.07%
Holding
39
New
1
Increased
10
Reduced
24
Closed
3
Top Buys
| 1 |
Vale
VALE
|
$5.82M |
| 2 |
Petrobras
PBR
|
$1.78M |
| 3 |
MTEM
Molecular Templates, Inc.
MTEM
|
$205K |
| 4 |
Fate Therapeutics
FATE
|
$135K |
| 5 |
Black Diamond Therapeutics
BDTX
|
$81.6K |
Top Sells
Sector Composition
| 1 | Healthcare | 47.91% |
| 2 | Materials | 11.06% |
| 3 | Energy | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MYOV
26
DELISTED
Myovant Sciences Ltd.
MYOV
| $353K | 0.41% |
25,111
-1,959
| -7% | -$27.5K |
|
27
Scholar Rock
SRRK
$3B
| $262K | 0.3% |
14,821
+13
| +0.1% | +$230 |
|
28
Nektar Therapeutics
NKTR
$747M
| $237K | 0.28% |
953
-29
| -3% | -$7.21K |
|
|
29
Black Diamond Therapeutics
BDTX
$166M
| $229K | 0.27% |
7,589
+2,703
| +55% | +$81.6K |
|
|
MTEM
30
DELISTED
Molecular Templates, Inc.
MTEM
| $205K | 0.24% |
+1,254
| New | +$205K |
|
31
Sangamo Therapeutics
SGMO
$166M
| $199K | 0.23% |
21,018
-626
| -3% | -$5.93K |
|
32
Voyager Therapeutics
VYGR
$233M
| $156K | 0.18% |
14,632
-438
| -3% | -$4.67K |
|
33
Wave Life Sciences
WVE
$1.32B
| $121K | 0.14% |
14,211
+705
| +5% | +$6K |
|
34
Kezar Life Sciences
KZR
$29.9M
| $112K | 0.13% |
2,315
+1,004
| +77% | +$48.6K |
|
35
Cidara Therapeutics
CDTX
$1.6B
| $44K | 0.05% |
770
-33
| -4% | -$1.89K |
|
36
Arvinas
ARVN
$584M
| – | – |
-6,974
| Closed | -$234K |
|
37
iShares Biotechnology ETF
IBB
$5.8B
| – | – |
-5,015
| Closed | -$686K |
|
38
Invesco QQQ Trust
QQQ
$368B
| – | – |
0
| – | – |
|
|
AKCA
39
DELISTED
Akcea Therapeutics, Inc. Common Stock
AKCA
| – | – |
-13,761
| Closed | -$189K |
|